Prader-Willi Syndrome



Computerized Response Training Obesity Treatment


Conditions:   Obesity;   Hyperphagia;   Feeding and Eating Disorders
Interventions:   Behavioral: Computer Based Response Training Weight Loss Intervention;   Behavioral: Generic Response Training Control Intervention
Sponsors:   Oregon Research Institute;   Flinders University;   University of Exeter;   Radboud University;   University of Oregon
Recruiting


Effects of Transcranial Direct Current Stimulation (tDCS) on Individuals With Prader-Willi Syndrome


Conditions:   Prader-Willi Syndrome;   Obesity;   Depressive Disorder;   Obsessive-Compulsive Disorder
Intervention:   Device: tDCS
Sponsor:   Federal University of São Paulo
Enrolling by invitation


A Study of GLWL-01 in Patients With Prader-Willi Syndrome


Condition:   Prader-Willi Syndrome
Interventions:   Drug: GLWL-01;   Drug: Placebo
Sponsor:   GLWL Research Inc.
Recruiting


B. Lactis B94 Effects of Gastrointestinal Function


Condition:   Quality of Life
Interventions:   Dietary Supplement: B. lactis B94;   Dietary Supplement: Placebo
Sponsors:   University of Florida;   Lallemand Health Solutions
Recruiting


Intranasal Oxytocin for Infants With Prader-Willi Syndrome


Condition:   Prader-Willi Syndrome
Interventions:   Drug: Oxytocin;   Drug: Placebo
Sponsor:   University of Florida
Completed


Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome


Conditions:   Prader-Willi Syndrome;   Hyperphagia
Interventions:   Drug: Intranasal Oxytocin (IN-OXT);   Drug: Matched Placebo
Sponsors:   Montefiore Medical Center;   FDA Office of Orphan Products Development
Not yet recruiting


Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)


Condition:   Confirmed Genetic Diagnosis of Prader-Willi Syndrome
Interventions:   Drug: Tesofensine/Metoprolol;   Drug: Placebos
Sponsor:   Saniona
Recruiting


Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years


Condition:   Prader-Willi Syndrome
Interventions:   Drug: Oxytocin;   Drug: Placebo
Sponsor:   University Hospital, Toulouse
Recruiting


Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory


Condition:   Prader-Willi Syndrome
Intervention:   Behavioral: Listening Project Protocol
Sponsors:   Indiana University;   Latham Centers
Recruiting


Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.


Condition:   Prader-Willi Syndrome
Interventions:   Drug: Oxytocin;   Other: Control
Sponsor:   University Hospital, Toulouse
Recruiting


Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome


Condition:   Prader-Willi Syndrome
Interventions:   Drug: Cannabidiol;   Drug: Placebo
Sponsor:   INSYS Therapeutics Inc
Not yet recruiting


Register of Patients With Prader-Willi Syndrome


Condition:   Prader-Willi Syndrome
Intervention:   Other: Data collection
Sponsor:   University Hospital, Toulouse
Recruiting


Effects of Noninvasive Brain Stimulation on Brain Activity and Appetite


Condition:   Hyperphagia
Intervention:   Device: Noninvasive brain stimulation
Sponsor:   Laval University
Recruiting


Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome


Conditions:   Prader-Willi Syndrome;   Hyperphagia
Interventions:   Drug: Intranasal Oxytocin (IN-OXT);   Drug: Matched Placebo
Sponsors:   Montefiore Medical Center;   Foundation for Prader-Willi Research
Active, not recruiting


Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma


Condition:   Neurofibromatosis Type 1
Interventions:   Device: Magnetic resonance imaging;   Drug: Gadolinium contrast
Sponsors:   Washington University School of Medicine;   St. Louis Children's Hospital
Recruiting


Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome


Conditions:   Metabolism and Nutrition Disorder;   Obesity
Interventions:   Drug: liraglutide;   Drug: placebo
Sponsor:   Novo Nordisk A/S
Recruiting


The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control


Conditions:   Lack of Satiety;   Hyperphagia
Interventions:   Other: Almonds;   Other: Cheese Savouries
Sponsors:   University of Leeds;   Almond Board of California
Completed


Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome


Conditions:   Prader Willi Syndrome;   Adrenal Insufficiency
Interventions:   Other: Low dose (1 mcg) ACTH stimulation test;   Other: Overnight metyrapone test
Sponsor:   Nationwide Children's Hospital
Completed


Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome


Condition:   Prader-Willi Syndrome
Interventions:   Drug: RM-493;   Drug: Placebo
Sponsor:   Rhythm Pharmaceuticals, Inc.
Completed


Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants


Condition:   Prader Willi Syndrome
Intervention:   Drug: oxytocin
Sponsor:   University Hospital, Toulouse
Completed


Effect of Massage Therapy in a Multisensory Environment for Intellectual Disabilities


Conditions:   Behavior Disturbance;   Muscle Hypotonia
Interventions:   Behavioral: Multisensory environment (MSE);   Behavioral: Massage therapy (MT);   Other: Control group;   Behavioral: Massage therapy in multisensory environment (MT-MSE)
Sponsor:   The Hong Kong Polytechnic University
Completed


Oxytocin Trial in Prader-Willi Syndrome


Condition:   Prader Willi Syndrome
Interventions:   Drug: Intranasal oxytocin;   Other: Placebo
Sponsors:   University of Florida;   National Institutes of Health (NIH)
Completed


Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome


Conditions:   Hyperphagia;   Prader-Willi Syndrome
Intervention:   Device: tDCS
Sponsors:   University of Kansas Medical Center;   Prader-Willi Syndrome Association USA;   Harvard Medical School;   Foundation for Prader-Willi Research
Completed


Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies


Condition:   Prader-Willi Syndrome
Intervention:   Drug: Oxytocin
Sponsor:   University Hospital, Toulouse
Completed


Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo


Condition:   Prader Willi Syndrome
Interventions:   Drug: Syntocinon®/- Spray;   Drug: Physiological serum (Sodium chloride)
Sponsor:   University Hospital, Toulouse
Completed

Refine Your Search Advanced Search